Evidence map›Paper›PMID 35100259›Full record

ArticlePLoS genetics2022

Neuroplastin genetically interacts with Cadherin 23 and the encoded isoform Np55 is sufficient for cochlear hair cell function and hearing.

Sherylanne Newton, Fanbo Kong, Adam J Carlton, Carlos Aguilar, Andrew Parker, Gemma F Codner, Lydia Teboul, Sara Wells, Steve D M Brown, Walter Marcotti and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. CaProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Presynaptic Nrxn3 is essential for ribbon-synapse assembly in hair cells.bioRxiv : the preprint server for biology · 2024
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Sherylanne NewtonMammalian Genetics Unit, MRC Harwell Institute, Harwell Oxford, United Kingdom.ORCID 0000-0002-8210-3526
Fanbo KongSchool of Sciences, University of Sheffield, Sheffield, United Kingdom.ORCID 0000-0003-3029-5500
Adam J CarltonSchool of Sciences, University of Sheffield, Sheffield, United Kingdom.ORCID 0000-0002-1054-3901
Carlos AguilarMammalian Genetics Unit, MRC Harwell Institute, Harwell Oxford, United Kingdom.ORCID 0000-0002-4655-1778
Andrew ParkerMammalian Genetics Unit, MRC Harwell Institute, Harwell Oxford, United Kingdom.
Gemma F CodnerMary Lyon Centre, MRC Harwell Institute, Harwell Oxford, United Kingdom.
Lydia TeboulMary Lyon Centre, MRC Harwell Institute, Harwell Oxford, United Kingdom.
Sara WellsMary Lyon Centre, MRC Harwell Institute, Harwell Oxford, United Kingdom.ORCID 0000-0002-0572-0600
Steve D M BrownMammalian Genetics Unit, MRC Harwell Institute, Harwell Oxford, United Kingdom.
Walter MarcottiSchool of Sciences, University of Sheffield, Sheffield, United Kingdom.ORCID 0000-0002-8770-7628
Michael R BowlMammalian Genetics Unit, MRC Harwell Institute, Harwell Oxford, United Kingdom.ORCID 0000-0001-7971-445X
Mary Lyon Centre at MRC Harwell · GBUniversity of Sheffield · GB

Funding

Biotechnology and Biological Sciences Research Council BB/S006257/1Medical Research Council MC_U142684172Medical Research Council MC_UP_1502/1Medical Research Council MC_UP_1503/2Medical Research Council MR/X004597/1
6 · The paper itself

Abstract

Mammalian hearing involves the mechanoelectrical transduction (MET) of sound-induced fluid waves in the cochlea. Essential to this process are the specialised sensory cochlear cells, the inner (IHCs) and outer hair cells (OHCs). While genetic hearing loss is highly heterogeneous, understanding the requirement of each gene will lead to a better understanding of the molecular basis of hearing and also to therapeutic opportunities for deafness. The Neuroplastin (Nptn) gene, which encodes two protein isoforms Np55 and Np65, is required for hearing, and homozygous loss-of-function mutations that affect both isoforms lead to profound deafness in mice. Here we have utilised several distinct mouse models to elaborate upon the spatial, temporal, and functional requirement of Nptn for hearing. While we demonstrate that both Np55 and Np65 are present in cochlear cells, characterisation of a Np65-specific mouse knockout shows normal hearing thresholds indicating that Np65 is functionally redundant for hearing. In contrast, we find that Nptn-knockout mice have significantly reduced maximal MET currents and MET channel open probabilities in mature OHCs, with both OHCs and IHCs also failing to develop fully mature basolateral currents. Furthermore, comparing the hearing thresholds and IHC synapse structure of Nptn-knockout mice with those of mice that lack Nptn only in IHCs and OHCs shows that the majority of the auditory deficit is explained by hair cell dysfunction, with abnormal afferent synapses contributing only a small proportion of the hearing loss. Finally, we show that continued expression of Neuroplastin in OHCs of adult mice is required for membrane localisation of Plasma Membrane Ca2+ ATPase 2 (PMCA2), which is essential for hearing function. Moreover, Nptn haploinsufficiency phenocopies Atp2b2 (encodes PMCA2) mutations, with heterozygous Nptn-knockout mice exhibiting hearing loss through genetic interaction with the Cdh23ahl allele. Together, our findings provide further insight to the functional requirement of Neuroplastin for mammalian hearing.

Indexed as

AnimalsCadherinsHair Cells, Auditory, InnerHearingLoss of Function MutationMembrane GlycoproteinsMiceMice, KnockoutPlasma Membrane Calcium-Transporting ATPasesProtein IsoformsCadherinsCdh23 protein, mouseMembrane Glycoproteinsneuroplastin protein, mousePlasma Membrane Calcium-Transporting ATPasesProtein Isoforms

Identifiers

PMID35100259
PMCPMC8830789
OpenAlexW4220734602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.